Daily FNArena News - Australia

Orica expects its first half will be weak but has resisted changing FY14 guidance, placing pressure on second half expectations.

Automotive Holdings will expand its footprint in logistics substantially, while adding another car dealership to its stable.

A wrap of the day’s activity on the Australian stock market.

Trading profits in US energy markets in particular have allowed Macquarie Group to define a solid profit increase for FY14, but is there anymore share price upside to be had?

The US FDA has approved Cochlear’s Nucleus Hybrid L24. It’s a welcome development but brokers remain focused on the challenges ahead.

A wrap of the day’s activity on the Australian stock market.

Metcash has revealed its eagerly-awaited strategy to put the business on a better footing and return to growth.

FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.

Weekly update on recommendation, target price, and earnings forecast changes.

A wrap of the day’s activity on the Australian stock market.